Canada markets open in 7 hours 5 minutes

Rite Aid Corporation (RAD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
16.14-1.26 (-7.24%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close17.40
Bid0.00 x 1000
Ask0.00 x 900
Day's Range15.89 - 17.00
52 Week Range8.86 - 32.48
Avg. Volume2,257,615
Market Cap889.101M
Beta (5Y Monthly)0.86
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct. 14, 1999
1y Target EstN/A
  • Business Wire

    Rite Aid Partners With CLEAR to Offer Digital Vaccine Card

    CAMP HILL, Pa., September 15, 2021--Rite Aid (NYSE: RAD) today announced a partnership with CLEAR (NYSE: YOU), the secure identity company, to offer Rite Aid customers the ability to access and share their proof of COVID-19 vaccination with CLEAR’s digital vaccine card and Health Pass. Customers vaccinated at any Rite Aid location can supplement their paper vaccination card with a verified digital version accessible on their mobile device.

  • Business Wire

    Rite Aid Brings Together Corporate Workforce Through Remote-First Collaboration

    PHILADELPHIA, September 14, 2021--Today, Rite Aid (NYSE: RAD) unveiled its corporate workplace of the future – a remote-first work approach for corporate associates, supported by a network of collaboration centers throughout the company’s geographic footprint. The reimagined workplace model focuses on flexibility for associates, while also creating an official headquarters space in Philadelphia designed specifically for in-person collaboration and company gatherings, rather than office spaces. R

  • Business Wire

    Lance Neill Joins Elixir as New Chief Operating Officer

    CAMP HILL, Pa., September 07, 2021--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD) that provides pharmacy benefits and services, today announced that veteran healthcare and pharmacy executive Lance Neill has joined the company as chief operating officer. Neill was most recently vice president of network development and contracting for Centene’s portfolio of managed care products, representing $32 billion in annual pharmacy spend. Prior to that, he served in multiple senior leadership